Literature DB >> 10682869

The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms.

A Bendich1.   

Abstract

Many types of dietary supplements have been advocated for the reduction of certain symptoms of premenstrual syndrome (PMS). However, only one supplement-calcium-has been demonstrated to be of significant benefit in a large, rigorous, double-blind, placebo-controlled trial. Limited evidence suggests that magnesium, vitamin E and carbohydrate supplements might also be useful, but additional research is needed to confirm these findings. Trials of vitamin B6 supplementation have had conflicting results, and high doses of this vitamin taken for prolonged periods of time can cause neurological symptoms. Trials of evening primrose oil have also had conflicting results; the two most rigorous studies showed no evidence of benefit. A variety of herbal products are suggested to reduce symptoms of PMS. The efficacy of these products is uncertain because of a lack of consistent data from scientific studies. Health professionals should be aware of the possible use of these supplements and ask those with PMS about their use of such products and counsel them based upon the totality of evidence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10682869     DOI: 10.1080/07315724.2000.10718907

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  14 in total

1.  Effects of St John's wort (Hypericum perforatum L.) extracts on epileptogenesis.

Authors:  Vesna Ivetic; Svetlana Trivic; Marija Knezevic Pogancev; Mira Popovic; Janka Zlinská
Journal:  Molecules       Date:  2011-09-19       Impact factor: 4.411

2.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

3.  The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Sarah Canning; Mitch Waterman; Nic Orsi; Julie Ayres; Nigel Simpson; Louise Dye
Journal:  CNS Drugs       Date:  2010-03       Impact factor: 5.749

Review 4.  Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part A: vitamins.

Authors:  Orit Kaidar-Person; Benjamin Person; Samuel Szomstein; Raul J Rosenthal
Journal:  Obes Surg       Date:  2008-03-04       Impact factor: 4.129

5.  Current problems of food intake in young women in Japan: Their influence on female reproductive function.

Authors:  Tomoko Fujiwara; Rieko Nakata
Journal:  Reprod Med Biol       Date:  2004-08-10

6.  The effect of Valerian root extract on the severity of pre menstrual syndrome symptoms.

Authors:  Zahra Behboodi Moghadam; Elham Rezaei; Roghaieh Shirood Gholami; Masomeh Kheirkhah; Hamid Haghani
Journal:  J Tradit Complement Med       Date:  2016-01-19

7.  Study Protocol for a Randomized Double Blind, Treatment Control Trial Comparing the Efficacy of a Micronutrient Formula to a Single Vitamin Supplement in the Treatment of Premenstrual Syndrome.

Authors:  Hannah Retallick-Brown; Julia Rucklidge; Neville Blampied
Journal:  Medicines (Basel)       Date:  2016-12-07

8.  The Association between the Risk of Premenstrual Syndrome and Vitamin D, Calcium, and Magnesium Status among University Students: A Case Control Study.

Authors:  Afsaneh Saeedian Kia; Reza Amani; Bahman Cheraghian
Journal:  Health Promot Perspect       Date:  2015-10-25

9.  Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome: A randomized, double-blind, controlled trial.

Authors:  Hajar Dadkhah; Elham Ebrahimi; Nahid Fathizadeh
Journal:  Iran J Nurs Midwifery Res       Date:  2016 Mar-Apr

10.  Cancer Prevention and Health Benefices of Traditionally Consumed Borago officinalis Plants.

Authors:  María-Dolores Lozano-Baena; Inmaculada Tasset; Andrés Muñoz-Serrano; Ángeles Alonso-Moraga; Antonio de Haro-Bailón
Journal:  Nutrients       Date:  2016-01-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.